We will be in touch shortly.
ClearFlow is a California-based medical device company, pioneering new technologies to solve the clinical problems associated with obstructed catheters.
ClearFlow was formed from the collaborative efforts of the Cleveland Clinic Foundation and MDI Partners.
Their platform of catheter systems aim to enable caregivers to actively clear internal obstructions, and ensure these critical tubes perform optimally. By reducing medical tube failure, Clear Catheter Systems' products can reduce complications and costs associated with medical tube failure.
The company’s product pipeline is based on its proprietary Active Clearance Technology® (ACT), which focuses on resolving catheter clogging in a range of clinical specialties, including urinary catheters, gastrointestinal catheters, and wound drainage.
ClearFlow’s mission is to improve patient outcomes and reduce healthcare costs by developing advanced technologies that support Best Practices and Guidelines to prevent chest tube occlusions.
They are committed to providing Clinicians with the tools they need to prevent Retained Blood Syndrome (RBS) from blocking patient’s recovery, with their end-goal being to advocate a new standard of care by creating solutions that can help prevent or reduce the risk of RBS.
As a provider of quality products, Device Technologies partners with ClearFlow to bring their solutions to the Australian healthcare market.
